Therapeutic Oligonucleotides, From Discovery to the Clinic The Avecia-TriLink AllianceTriLink has teamed up with Avecia to enable you to easily transition from R&D and pre-clinical studies to clinical trials and commercial manufacture of therapeutic oligonucleotides. Working with this alliance minimizes your challenges and risks associated with transitioning from a research-grade vendor to an oligonucleotide development service and manufacturing company. We have harmonized our processes, so you can enjoy a smooth changeover when scaling up for clinical trials. With over 130 clinical trials and 30 years combined experience in manufacturing, the Avecia-TriLink Team is the leader in therapeutic oligonucleotide technology and program development.
About the Alliance
TriLink and Avecia have shared technology platforms, analytical methods, protocols and material samples to ensure a faster and easier scale-up of your compound. This harmonization allows the material you use in the clinic to more accurately represent the material used in pre-clinical investigations. This scale-up solution offers you more regulatory simplicity, less risk, as well as savings in time and costs.
The common technology platform between TriLink and Avecia removes potential hurdles ensuring a worry-free transition from development through to the clinic.
Features
Benefits
Common technology and analytical platforms
Reduced risk of repeating pre-clinical investigations ahead of clinical trials
About Avecia Avecia is the world leader in the manufacture of cGMP oligonucleotides and has over 10 years experience in the production of DNA, RNA, siRNA, Molecular Decoys, Chimeras and Aptamers. Avecia’s FDA registered facility in Milford, Massachusetts, manufactures active pharmaceutical ingredients (API) meeting the international requirements addressed by ICH Q7A.
As the manufacturing partner for over 130 clinical trials, Avecia has the experience and quality system to help you achieve your goals. Avecia is able to understand your oligonucleotide drug development needs, and support you at all key stages from
pre-clinical testing and toxicology through drug launch.
